Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more
Sunzen Biotech Bhd (0148) - Total Liabilities
Latest total liabilities as of March 2024: RM18.73 Million MYR
Based on the latest financial reports, Sunzen Biotech Bhd (0148) has total liabilities worth RM18.73 Million MYR as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sunzen Biotech Bhd - Total Liabilities Trend (2016–2023)
This chart illustrates how Sunzen Biotech Bhd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sunzen Biotech Bhd Competitors by Total Liabilities
The table below lists competitors of Sunzen Biotech Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
I Yuan Precision Ind Co Ltd
TWO:2235
|
Taiwan | NT$184.00 Million |
|
355690
KQ:355690
|
Korea | ₩30.68 Billion |
|
Kaanapali Land LLC
PINK:KANP
|
USA | $9.61 Million |
|
Trust Stamp Inc
NASDAQ:IDAI
|
USA | $4.97 Million |
|
Global Blockchain Acquisition Corp. Common Stock
NASDAQ:GBBK
|
USA | $2.94 Million |
|
Jian Sin Industrial Co Ltd
TWO:4502
|
Taiwan | NT$1.75 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down Sunzen Biotech Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sunzen Biotech Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sunzen Biotech Bhd (2016–2023)
The table below shows the annual total liabilities of Sunzen Biotech Bhd from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | RM20.51 Million | -29.46% |
| 2022-12-31 | RM29.08 Million | -5.01% |
| 2021-12-31 | RM30.61 Million | -14.34% |
| 2020-12-31 | RM35.73 Million | -3.32% |
| 2019-12-31 | RM36.96 Million | -9.05% |
| 2018-12-31 | RM40.63 Million | +106.30% |
| 2017-12-31 | RM19.70 Million | +119.33% |
| 2016-12-31 | RM8.98 Million | -- |